TY  - JOUR
TI  - A Case of Cutaneous Leishmaniasis Responding to Systemic Liposomal Amphotericin B Treatment
AB  - Leishmania is a vector-induced endemic tropical disease caused by pro-tozoans. The most common cutaneous, mucosal and visceral forms are the cutaneous form. The main drugs in treatment are pentavalent anti-mony compounds, but their side effects create limitation of use. Local antimony compounds are used primarily in the treatment of cutane-ous leishmaniasis. In some cases, alternative treatment modalities are required due to insufficient response to local treatment. Systemic am-photericin B treatment is one of the alternative treatments. In a patient who developed cutaneous Leishmania at 21 months and who did not respond with local meglumine antimoniate therapy, a total of 21 mg/kg dose of systemic amphotericin B was given intermittently and successful results were obtained.
AU  - TAŞKIN, ESRA
AU  - İnce, Erdal
AU  - Konca, Hatice Kubra
AU  - Özdemir, Halil
AU  - arga, gul
AU  - Akay, Bengu Nisa
AU  - Çiftçi, Ergin
AU  - Kütükçü, Hatice büşra
DO  - 10.5578/ced.202069
PY  - 2020
JO  - Çocuk Enfeksiyon Dergisi
VL  - 14
IS  - 4
SN  - 1307-1068
SP  - 229
EP  - 232
DB  - TRDizin
UR  - http://search/yayin/detay/416859
ER  -